Plug Power Inc (NASDAQ:PLUG) will be profitable by the end of the year and the company expects to announce two or three major deals in 2014. During the first three months of 2014, orders have already topped 2013 orders, so facts are the reason for optimism, Chief Executive Officer Andy Marsh told MarketWatch Friday. The fuel-cell supplier should break even in the third quarter and report profits by the fourth quarter, he said. Plug, founded in the late 1990s, has never been profitable. Plug Power Inc (NASDAQ:PLUG) shares after opening at $7.47 on last trade day and at the end of the day closed at $6.71. Company price to sales ratio in past twelve months was calculated as 23.05 and price to cash ratio as 51.33. Plug Power Inc (NASDAQ:PLUG) showed a negative weekly performance of -18.86%.
Aeropostale Inc (NYSE:ARO) shares slumped 20%. The teen retailer late Thursday reported a wider-than-expected adjusted loss in the fourth quarter of 35 cents a share. Quarterly sales fell 16% to $670 million from $797.7 million a year earlier, also falling short of analyst estimates. Same-store sales slumped 15%. Separately, Aeropostale said it had agreed to enter a strategic partnership with Sycamore Partners. The deal gives the retailer a $150 million loan and in return, Aeropostale will issue convertible preferred stock to Sycamore, giving the firm the right to buy up to 5% of common stock. Aeropostale Inc (NYSE:ARO) shares fell -20.14% in last trading session and ended the day on $5.83. ARO return on equity ratio is recorded as -19.00% and its return on assets is -9.90%. Aeropostale Inc (NYSE:ARO) yearly performance is -59.82%.
Omeros Corporation (NASDAQ:OMER) announced that it has priced an underwritten public offering of 3,043,479 shares of its common stock at a price to the public of $11.50 per share for gross proceeds of $35.0 million. The net proceeds from the sale of the shares, after deducting the underwriters’ discounts and other estimated offering expenses, will be approximately $32.8 million. Omeros has also granted the underwriters a 30-day option to purchase up to an additional 456,521 shares of common stock to cover overallotments, if any, which would result in additional gross proceeds of approximately $5.2 million if exercised in full. Omeros Corporation (NASDAQ:OMER) shares moved down -7.72%in last trading session and was closed at $11.35, while trading in range of $11.00 – $11.59. Omeros Corporation (NASDAQ:OMER) year to date (YTD) performance is 0.53%.
TESARO Inc (NASDAQ:TSRO), this week announced an exclusive, worldwide license agreement and immuno-oncology antibody collaboration. Under the terms of the agreement, Tesaro receives rights to monospecific antibody drug candidates targeting TIM-3, LAG-3 and PD-1 and dual reactive antibody drug candidates targeting PD-1/TIM-3 and PD-1/LAG-3. Therapeutic antibodies selected from these programs will form the basis of a strategic platform that will enable Tesaro to develop novel monotherapy and combination-based approaches with immuno-oncology and other anti-cancer agents in a variety of indications. Antibody candidates from these programs are expected to enter clinical trials over the next 18 to 24 months. TESARO Inc (NASDAQ:TSRO) weekly performance is 21.88%. On last trading day company shares ended up $36.76. TESARO Inc (NASDAQ:TSRO) distance from 50-day simple moving average (SMA50) is 18.34%. Analysts mean target price for the company is $44.14.
Leave a Reply